KR102409134B1 - 의사소통 기술의 개선을 위한 인지질 제제 - Google Patents

의사소통 기술의 개선을 위한 인지질 제제 Download PDF

Info

Publication number
KR102409134B1
KR102409134B1 KR1020177016965A KR20177016965A KR102409134B1 KR 102409134 B1 KR102409134 B1 KR 102409134B1 KR 1020177016965 A KR1020177016965 A KR 1020177016965A KR 20177016965 A KR20177016965 A KR 20177016965A KR 102409134 B1 KR102409134 B1 KR 102409134B1
Authority
KR
South Korea
Prior art keywords
formulation
percentage
bound
acid
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177016965A
Other languages
English (en)
Korean (ko)
Other versions
KR20170095246A (ko
Inventor
레게브 다프나 자아루어
로버트 쿠드노
야엘 리터
아치 갈리 올가 소리아
Original Assignee
프루타롬 엘티디.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프루타롬 엘티디. filed Critical 프루타롬 엘티디.
Publication of KR20170095246A publication Critical patent/KR20170095246A/ko
Application granted granted Critical
Publication of KR102409134B1 publication Critical patent/KR102409134B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020177016965A 2014-11-20 2015-11-19 의사소통 기술의 개선을 위한 인지질 제제 Active KR102409134B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462082261P 2014-11-20 2014-11-20
US62/082,261 2014-11-20
PCT/IB2015/002391 WO2016079595A2 (en) 2014-11-20 2015-11-19 Phospholipid preparations for the improvement of communication skills

Publications (2)

Publication Number Publication Date
KR20170095246A KR20170095246A (ko) 2017-08-22
KR102409134B1 true KR102409134B1 (ko) 2022-06-16

Family

ID=54337183

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177016965A Active KR102409134B1 (ko) 2014-11-20 2015-11-19 의사소통 기술의 개선을 위한 인지질 제제

Country Status (12)

Country Link
US (1) US20170360812A1 (enExample)
EP (1) EP3220753B1 (enExample)
JP (1) JP6787891B2 (enExample)
KR (1) KR102409134B1 (enExample)
CN (1) CN107249581B (enExample)
AU (1) AU2015348010B2 (enExample)
CA (1) CA2967895C (enExample)
ES (1) ES2745226T3 (enExample)
IL (1) IL252302B (enExample)
NZ (1) NZ733019A (enExample)
SG (1) SG11201703944XA (enExample)
WO (1) WO2016079595A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117918425B (zh) * 2024-03-05 2025-01-24 广州迪卡德营养科技有限公司 一种提高记忆学习功能的神经酸组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10149108A1 (de) * 2001-10-05 2003-04-30 Degussa Bioactives Deutschland Verwendung von Phosphatidylserin zur Behandlung des Aufmerksamkeits-Defizit-Syndroms (ADHS)
IL158553A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Method for preparing phosphatidylserine containing omega-3 acid moieties
IL158552A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Lipids containing omega-3 fatty acids
US7935365B2 (en) * 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
SI1559430T1 (sl) * 2004-01-29 2009-08-31 Indena Spa Uporaba kompleksov ginkga za izboljĺ anje kognitivnih funkcij in ublaĺ˝itev duĺ evne izäśrpanosti
KR20120051458A (ko) * 2010-11-12 2012-05-22 주식회사 두산 크릴 인지질을 이용하여 아스타잔틴 및 ｄｈａ－ 및/또는 ｅｐａ－결합된 포스파티딜세린을 함유한 조성물을 제조하는 방법 및 이러한 방법에 의해 제조된 조성물
US10052319B2 (en) * 2012-04-26 2018-08-21 Sumitomo Dainippon Pharma Co., Ltd. Medicament for treating mental and behavioural disorders
US10688070B2 (en) * 2013-12-05 2020-06-23 Enzymotec Ltd. Serine glycerophospholipid preparation and method for treatment of seizures

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
인터넷 뉴스(업코리아, 건국대 나승렬 교수 연구팀, 인삼서 치매예방 새 생리활성물질 규명, 2012.05.11)

Also Published As

Publication number Publication date
SG11201703944XA (en) 2017-06-29
WO2016079595A3 (en) 2016-07-14
JP6787891B2 (ja) 2020-11-18
IL252302B (en) 2021-04-29
AU2015348010B2 (en) 2020-02-27
CN107249581A (zh) 2017-10-13
CN107249581B (zh) 2021-10-15
US20170360812A1 (en) 2017-12-21
IL252302A0 (en) 2017-07-31
NZ733019A (en) 2021-12-24
WO2016079595A2 (en) 2016-05-26
JP2017536367A (ja) 2017-12-07
EP3220753A2 (en) 2017-09-27
EP3220753B1 (en) 2019-07-17
ES2745226T3 (es) 2020-02-28
CA2967895C (en) 2021-09-07
AU2015348010A1 (en) 2017-07-13
CA2967895A1 (en) 2016-05-26
KR20170095246A (ko) 2017-08-22

Similar Documents

Publication Publication Date Title
US9962455B2 (en) Glycerophospholipids for the improvement of cognitive functions
RU2611808C2 (ru) Липидная смесь для детского питания
US10894056B2 (en) Phospholipid preparations for the improvement of sleep
KR102409134B1 (ko) 의사소통 기술의 개선을 위한 인지질 제제
US10688070B2 (en) Serine glycerophospholipid preparation and method for treatment of seizures
US10888573B2 (en) Phospholipid preparations for the improvement of brain plasticity

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170620

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201105

Comment text: Request for Examination of Application

PA0302 Request for accelerated examination

Patent event date: 20201105

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210311

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20211130

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210311

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
PN2301 Change of applicant

Patent event date: 20220224

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20211130

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20210913

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20201105

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20220310

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20220302

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20211130

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20210913

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20201105

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220610

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220613

End annual number: 3

Start annual number: 1

PG1601 Publication of registration